IFFO2 Promotes Tumor Progression and Serves as a Prognostic Biomarker in Liver Hepatocellular Carcinoma
Functional enrichment analysis revealed that IFFO2 is significantly associated with immune regulation, cell cycle, and complement activation pathways, and its strong association with adverse prognosis and its potential to modulate the immune microenvironment underscore its dual potential as a diagnostic biomarker and a promising therapeutic target.